Central District

Jury Fully Rejects SPI’s Meritless Lawsuit Against FIGS

Retrieved on: 
Friday, November 4, 2022
Fashion, Online Retail, Retail, Health, Other Health, General Health, SPI, Central District, Hon, NYSE, LLP, Joint, Munger, Tolles & Olson, Atlantic Film Festival, District court, P.C, Patient, Public relations, Barbara Nessim

The decision by the jury follows four years of litigation pursued by SPI, one of the largest legacy players in the medical apparel market, in an attempt to stifle FIGS growth.

Key Points: 
  • The decision by the jury follows four years of litigation pursued by SPI, one of the largest legacy players in the medical apparel market, in an attempt to stifle FIGS growth.
  • This verdict is a powerful win, not only for FIGS, but for fair competition, said Todd Maron, Chief Legal Officer at FIGS.
  • This marks the end of a nasty, four-year campaign against FIGS, engineered by SPIs former CEO Mike Singer and based on outright falsehoods.
  • FIGS is a founder-led, direct-to-consumer healthcare apparel and lifestyle brand that seeks to celebrate, empower and serve current and future generations of healthcare professionals.

FULGENT GENETICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Fulgent Genetics, Inc. - FLGT

Retrieved on: 
Wednesday, November 2, 2022
Accusative case, Security (finance), Central District, KSF, Genetics, District court, U.S. Securities and Exchange Commission, News, SEC, Battle of Saint-Fulgent, GLOBE, LLC, Stark Law, Anti-Kickback Statute, Court, Justice, Civil investigative demand, Office of Inspector General, U.S. Department of Health and Human Services, U.S. Department of Justice Office of Legislative Affairs, Company, Remuneration, Private investigator

This action is pending in the United States District Court for the Central District of California.

Key Points: 
  • This action is pending in the United States District Court for the Central District of California.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by November 21, 2022.
  • Fulgent and certain of its executives are charged with failing to disclose material information during the Class Period, violating federal securities laws.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

CENTESSA PHARMACEUTICALS PLC (NASDAQ: CNTA) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Centessa Pharmaceuticals plc (NASDAQ: CNTA)

Retrieved on: 
Tuesday, November 1, 2022
Company, Securities Exchange Act of 1934, Central District, DNA, American depositary receipt, BID, District court, IPO, Liver, News, SEC, GLOBE, AE, Prospectus, AATD, Securities Act of 1933, Register, The Legal 500, Labour government, Court, ADS, Form, NEW, CNTA, NASDAQ, Investment, Observation, Polycystic kidney disease, Patient, American, A1AT, Advertising, Autosome, Defendant, Registration statement, Pharmaceutical industry, Security (finance)

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or otherwise acquired: (a) Centessa Pharmaceuticals plc (“Centessa” or the “Company”) (NASDAQ: CNTA) American Depositary Shares (“ADSs”) pursuant and/or traceable to the Offering Documents issued in connection with the Company’s initial public offering conducted on or about May 28, 2021 (the “IPO” or “Offering”); and/or (b) Centessa securities between May 28, 2021 and June 1, 2022, both dates inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Act of 1933 and Securities Exchange Act of 1934.

Key Points: 
  • If so, please visit Centessa Pharmaceuticals plc Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Centessa is a clinical-stage pharmaceutical company that purports to discover, develop, and deliver medicines to patients.
  • Plaintiff alleges that Defendants made materially false and misleading statements in the Offering Documents and throughout the Class Period.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

FULGENT GENETICS, INC. (NASDAQ: FLGT) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Fulgent Genetics, Inc. (NASDAQ: FLGT)

Retrieved on: 
Tuesday, November 1, 2022
Company, Health, Central District, Disclosure, Securities Exchange Act of 1934, Genetics, District court, News, SEC, Battle of Saint-Fulgent, GLOBE, Anti-Kickback Statute, COVID-19, Physician, The Legal 500, Court, Labour government, Stark, Justice, NEW, Investment, NASDAQ, Genetic testing, Reward, U.S. Department of Justice Office of Legislative Affairs, Office of Inspector General, U.S. Department of Health and Human Services, Medicare, Remuneration, Patient, Advertising, Stark Law, Tobacco, Pharmaceutical industry, Security (finance)

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Fulgent Genetics, Inc. (“Fulgent” or the “Company”) (NASDAQ: FLGT) between March 22, 2019 and August 4, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • Fulgent, together with its subsidiaries, provides COVID-19, molecular diagnostic, and genetic testing services to physicians and patients in the United States and internationally.
  • If you purchased Fulgent securities, and/or would like to discuss your legal rights and options please visit Fulgent Genetics, Inc.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

TWITTER, INC. (NYSE: TWTR) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against Twitter, Inc. (NYSE: TWTR)

Retrieved on: 
Tuesday, November 1, 2022
Company, TWTR, Central District, Disclosure, Securities Exchange Act of 1934, Congress, FTC, District court, News, CNN, SEC, GLOBE, Democracy, NYSE, Risk, The Legal 500, Confidentiality, Labour government, Court, Privacy, NEW, Investment, Social media, Federal Trade Commission, Complaint, Advertising, Class, Sales, Public relations, Twitter

NEW YORK, Nov. 01, 2022 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit that has been filed on behalf of investors who purchased or acquired the securities of Twitter, Inc. (“Twitter” or the “Company”) (NYSE: TWTR) between August 3, 2020 and August 23, 2022, inclusive (the “Class Period”). The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.

Key Points: 
  • Shareholder Class Action Lawsuit or contact Peter Allocco at (212) 951-2030 or [email protected] to discuss your rights.
  • The lawsuit was filed in the United States District Court for the Central District of California and alleges violations of the Securities Exchange Act of 1934.
  • Twitter purports to be a global social media platform for public self-expression and conversation in real time.
  • The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414.

FIGS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors With Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against FIGS, Inc. - FIGS

Retrieved on: 
Wednesday, November 2, 2022
Class Action Lawsuit, Professional Services, Legal, Central District, KSF, EBITDA, District court, News, LLC, NYSE, Register, Special warfare combatant-craft crewmen, Court, Ryan v. Valencia Gonzales, Company, Prospectus, Renewable energy

This action is pending in the United States District Court for the Central District of California.

Key Points: 
  • This action is pending in the United States District Court for the Central District of California.
  • If you wish to serve as a lead plaintiff in this class action, you must petition the Court by January 3, 2023.
  • On this news, the price of FIGS shares plummeted, falling approximately 25% to close at $9.64 per share.
  • About Kahn Swick & Foti, LLC
    KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nations premier boutique securities litigation law firms.

Robbins LLP Announces It Has Filed a Securities Fraud Lawsuit Against FIGS, Inc. (FIGS)

Retrieved on: 
Tuesday, November 1, 2022
Class Action Lawsuit, Professional Services, Legal, Steps, Douglas v. U.S. District Court ex rel Talk America, Central District, Securities Exchange Act of 1934, EBITDA, Registration statement, District court, IPO, Mask, News, Advertising, Time, Court, NYSE, COVID-19, Register, Securities Act of 1933, Person, Tax, Company, Electric Bond and Share Company v. Securities and Exchange Commission, Complaint, Depreciation, Security (finance)

The complaint alleges violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and U.S. Securities and Exchange Commission Rule 10b-5, promulgated thereunder, and section 11 of the Securities Act of 1933.

Key Points: 
  • The complaint alleges violations of sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and U.S. Securities and Exchange Commission Rule 10b-5, promulgated thereunder, and section 11 of the Securities Act of 1933.
  • The complaint seeks relief on behalf of the named plaintiff and all other similarly situated holders of FIGS during the Class Period.
  • The named plaintiff is represented by Robbins LLP.
  • The Registration Statement blamed the COVID-19 pandemic for the use of air freight in the time leading up to the IPO.

Crow Vote Victorious in Federal Court Lawsuit

Retrieved on: 
Tuesday, November 1, 2022
Marketing, Newport News, Virginia, Complaint, Judgement, Central District, Organic, Motion, Plaintiff, Court, The Honourable

LOS ANGELES, Nov. 1, 2022 /PRNewswire/ -- On Oct. 7, 2022 a federal judge ruled in favor of Crow Vote LLC, a digital marketing and software solutions company focused on cause-based marketing, after two former participants in an online competition, "Favorite Chef", had filed a lawsuit in early 2021 alleging the competition operated on Crow Vote's software platform violated state and federal law — The court ultimately found the competition to be lawfully operated and dismissed the case against Crow Vote in its entirety.

Key Points: 
  • LOS ANGELES, Nov. 1, 2022 /PRNewswire/ -- On Oct. 7, 2022 a federal judge ruled in favor of Crow Vote LLC, a digital marketing and software solutions company focused on cause-based marketing, after two former participants in an online competition, "Favorite Chef", had filed a lawsuit in early 2021 alleging the competition operated on Crow Vote's software platform violated state and federal law The court ultimately found the competition to be lawfully operated and dismissed the case against Crow Vote in its entirety.
  • Crow Vote had contended from the onset of the case that it had complied with applicable law in operating the competition and the federal court agreed.
  • "These decisions validate what we at Crow Vote have said from the beginning, that we have always operated within the bounds of the law," said a spokesperson for Crow Vote.
  • Crow Vote is a full-service digital marketing and software solutions company based in the U.S. that focuses on cause-based marketing efforts.

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Fulgent Genetics, Inc. of Class Action Lawsuit and Upcoming Deadline – FLGT

Retrieved on: 
Sunday, October 30, 2022
Reward, NASDAQ, Court, COVID-19, District court, Anti-Kickback Statute, LLP, Genetics, SEC Rule 10b-5, Federal, Justice, Person, Remuneration, Securities Exchange Act of 1934, Office of Inspector General, U.S. Department of Health and Human Services, Company, Complaint, GLOBE, Physician, U.S. Securities and Exchange Commission, Stark Law, SEC, Pomerantz, Patient, Central District, News, U.S. Department of Justice Office of Legislative Affairs, Medicare, Genetic testing, Battle of Saint-Fulgent, Health, Ext, Disclosure, Pharmaceutical industry

NEW YORK, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and certain of its officers.

Key Points: 
  • NEW YORK, Oct. 30, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Fulgent Genetics, Inc. (Fulgent or the Company) (NASDAQ: FLGT) and certain of its officers.
  • If you are a shareholder who purchased Fulgent securities during the Class Period, you have until November 21, 2022 to ask the Court to appoint you as Lead Plaintiff for the class.
  • To discuss this action, contact Robert S. Willoughby at [email protected] or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

FTC, California Act to Stop Ygrene Energy Fund from Deceiving Consumers About PACE Financing, Placing Liens on Homes Without Consumers’ Consent

Retrieved on: 
Monday, October 31, 2022
Consumer protection, Commission, Program, Douglas v. U.S. District Court ex rel Talk America, Risk, Social media, FTC, State, Federal Trade Commission, Blog, Deception, Complaint, Sale, Central District, News, Federal Trade Commission Act of 1914, District court, Real estate, Insurance, Dietary supplement, Property management

The Federal Trade Commission and State of California are taking action

Key Points: 
  • The Federal Trade Commission and State of California are taking action
    against home improvement financing provider Ygrene Energy Fund Inc. for deceiving consumers about the potential financial impact of its financing, and for unfairly recording liens on consumers homes without their consent.
  • Our proposed order would require Ygrene to clean up its business practices, monitor its sales force, and help defrauded consumers remove their liens.
  • Ygrene Energy Fund took advantage of hardworking California families, jeopardizing their most valuable asset in the process, said California Attorney General Rob Bonta.
  • California-based Ygrene has provided PACE financing, a form of secured home-improvement financing, for clean-energy home improvements in parts of California, Missouri, and Florida.
  • These sales often happen door-to-door, with contractors approaching consumers in their homes, selling both the energy upgrade and the supposed benefits of Ygrenes PACE financing.
  • PACE financing is a relatively new form of financing that relies on the property-tax system to collect payments from consumers.
  • Trapping consumers with PACE liens without clear consent: In many cases, Ygrene relies on an electronic signing system for its financing agreements with consumers.
  • In other cases, the contractor has forged the consumers signature by e-signing the contract without the consumers authorization.